Efficacy of an early administration of L0013CP 10 MG/DAY versus placebo during 4 weeks in the treatment of infectious diseases induced arthritis painful symptoms. A multicenter, randomised, double-blind, placebo controlled clinical trial in adult pa
Efficacy of an early administration of L0013CP 10 MG/DAY versus placebo during 4 weeks in the treatment of infectious diseases induced arthritis painful symptoms. A multicenter, randomised, double-blind, placebo controlled clinical trial in adult pa
Efficacy of an early administration of L0013CP 10 MG/DAY versus placebo during 4 weeks in the treatment of infectious diseases induced arthritis painful symptoms. A multicenter, randomised, double-blind, placebo controlled clinical trial in adult patients suffering from Chikungunya fever
Status
Status :
Early termination
Type of study
Phase III
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Infectiouos Desease
Disease :
Chikungunia
Study medication :
L0013
Phase :
Phase III
Start Date :
2006
Study ID :
L00013 CP 301
EudraCT/CTIS number :
2006-006165-17
Send by email